CurePSP Recognizes Three Prominent Medical Institutions for Their Care for PSP, CBD and MSA
PSP, CBD and MSA, which are considered "atypical parkinsonian syndromes," often go underrecognized and underdiagnosed.
- PSP, CBD and MSA, which are considered "atypical parkinsonian syndromes," often go underrecognized and underdiagnosed.
- Additionally, autonomic dysfunction (e.g., blood pressure regulation, urinary control) is a hallmark feature of MSA, while PSP and CBD can present with cognitive impairment and difficulty expressing words.
- "The continued growth of our care network is one impactful way we can work toward improving the standard of care for PSP, CBD and MSA."
- "Through becoming a CurePSP Center of Care, our ability to care for our patients will only expand and strengthen," Dr. Brown said.